Carotenoids and cardiovascular health.
暂无分享,去创建一个
Tiina H Rissanen | Sari Voutilainen | Tarja Nurmi | J. Mursu | S. Voutilainen | T. Nurmi | T. Rissanen | Jaakko Mursu
[1] A. Rao,et al. Tomato lycopene and low density lipoprotein oxidation: A human dietary intervention study , 1998, Lipids.
[2] A. Reunanen,et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. , 1994, American journal of epidemiology.
[3] D. Spiegelman,et al. Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake. , 2002, The American journal of clinical nutrition.
[4] V. Böhm,et al. Intestinal absorption of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma , 1999, European journal of nutrition.
[5] J. Mares-Perlman,et al. Human serum carotenoid concentrations are related to physiologic and lifestyle factors. , 1996, The Journal of nutrition.
[6] D. Morel,et al. Dietary supplementation with beta-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein. , 1999, Free radical biology & medicine.
[7] J. Olson. Biological actions of carotenoids. , 1989, The Journal of nutrition.
[8] W. Stahl,et al. Lycopene: a biologically important carotenoid for humans? , 1996, Archives of biochemistry and biophysics.
[9] Rongling Li,et al. Provitamin A carotenoid intake and carotid artery plaques: the Atherosclerosis Risk in Communities Study. , 1998, The American journal of clinical nutrition.
[10] D. Townsend,et al. The role of carotenoids in the prevention of human pathologies. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[11] G. Omenn,et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. , 1996, The New England journal of medicine.
[12] D. Albanes,et al. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.
[13] P. Di Mascio,et al. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. , 1989, Archives of biochemistry and biophysics.
[14] C. la Vecchia,et al. Beta-carotene intake and risk of nonfatal acute myocardial infarction in women , 1997, European Journal of Epidemiology.
[15] D. Albanes,et al. Intake of Flavonoids, Carotenoids, Vitamins C and E, and Risk of Stroke in Male Smokers , 2000, Stroke.
[16] A. Hofman,et al. Serum carotenoids and atherosclerosis. The Rotterdam Study. , 2000, Atherosclerosis.
[17] R. Collins,et al. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[18] A. Nissinen,et al. Food intake patterns and 25-year mortality from coronary heart disease: Cross-cultural correlations in the Seven Countries Study , 1999, European Journal of Epidemiology.
[19] A. Hofman,et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. , 1999, The American journal of clinical nutrition.
[20] T. G. Truscott,et al. Carotenoid radical chemistry and antioxidant/pro-oxidant properties. , 2004, Archives of biochemistry and biophysics.
[21] N. Krinsky. Actions of carotenoids in biological systems. , 1993, Annual review of nutrition.
[22] J. Buring,et al. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in men. , 2005, The American journal of clinical nutrition.
[23] D. L. Morris,et al. Serum carotenoids and coronary heart disease. The Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. , 1994, JAMA.
[24] G. Williamson,et al. A critical assessment of some biomarker approaches linked with dietary intake , 2001, British Journal of Nutrition.
[25] J. Buring,et al. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. , 2004, The American journal of clinical nutrition.
[26] J. Potter,et al. Plasma carotenoids as biomarkers of vegetable and fruit intake. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[27] S. Ripatti,et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. , 1997, Lancet.
[28] E. Rimm,et al. Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States , 1999, Annals of Internal Medicine.
[29] W. Stahl,et al. cis-trans isomers of lycopene and beta-carotene in human serum and tissues. , 1992, Archives of biochemistry and biophysics.
[30] F. Kok,et al. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study , 1993, The Lancet.
[31] E. Rimm,et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. , 2004, The American journal of clinical nutrition.
[32] J. Manson,et al. Dietary carotenoids and risk of coronary artery disease in women. , 2003, The American journal of clinical nutrition.
[33] D. Albanes,et al. Effect of α-tocopherol and β-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study , 2004 .
[34] T. Lakka,et al. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study , 2001, British Journal of Nutrition.
[35] F. Kok,et al. Lycopene and myocardial infarction risk in the EURAMIC Study. , 1997, American journal of epidemiology.
[36] S. Kiechl,et al. High plasma levels of alpha- and beta-carotene are associated with a lower risk of atherosclerosis: results from the Bruneck study. , 2000, Atherosclerosis.
[37] J. Erdman,et al. Bioavailability of all-trans and cis-Isomers of Lycopene , 2002 .
[38] Tw. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002, The Lancet.
[39] A. Folsom,et al. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis Risk in Communities. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[40] D. Albanes,et al. Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. , 2004, European heart journal.
[41] R. Parker,et al. Carotenoids in human blood and tissues. , 1989, Journal of NutriLife.
[42] R. Salkeld,et al. Serum Antioxidants and Myocardial Infarction: Are Low Levels of Carotenoids and α‐ Tocopherol Risk Factors for Myocardial Infarction? , 1994, Circulation.
[43] A. Dyer,et al. Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the Western Electric Study. , 1997, Neuroepidemiology.
[44] A. Edwards,et al. Bioavailability of carotenoids in human subjects , 1999, Proceedings of the Nutrition Society.
[45] J. Salonen,et al. Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. , 2003, The American journal of clinical nutrition.
[46] S. Ripatti,et al. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction , 1997, The Lancet.
[47] J. Manson,et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.
[48] J M Holden,et al. Carotenoid content of fruits and vegetables: an evaluation of analytic data. , 1993, Journal of the American Dietetic Association.
[49] J. Hautvast,et al. Dietary factors that affect the bioavailability of carotenoids. , 2000, The Journal of nutrition.
[50] M. Karagas,et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. , 1997, JAMA.
[51] G. Rechkemmer,et al. Moderate intervention with carotenoid-rich vegetable products reduces lipid peroxidation in men. , 2000, The Journal of nutrition.
[52] W. Willett,et al. Prospective Study of Plasma Carotenoids and Tocopherols in Relation to Risk of Ischemic Stroke , 2004, Stroke.
[53] W. Stahl,et al. cis-trans isomers of lycopene and β-carotene in human serum and tissues , 1992 .
[54] W. Willett,et al. Plasma Carotenoids and Tocopherols and Risk of Myocardial Infarction in a Low-Risk Population of US Male Physicians , 2003, Circulation.
[55] Walter C Willett,et al. Optimal diets for prevention of coronary heart disease. , 2002, JAMA.
[56] F. Kok,et al. Antioxidants in adipose tissue and myocardial infarcation in a Mediterranean area. The EURAMIC study in M laga. , 1997 .
[57] H. Stähelin,et al. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke Basel Prospective Study , 2004, The clinical investigator.
[58] A. Coats. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[59] Nea Malila,et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. , 2003, JAMA.
[60] D. Morel,et al. Dietary supplementation with β-carotene, but not with lycopene, inhibits endothelial cell-mediated oxidation of low-density lipoprotein , 1999 .
[61] J. Salonen,et al. Low Plasma Lycopene Concentration Is Associated With Increased Intima-Media Thickness of the Carotid Artery Wall , 2000, Arteriosclerosis, thrombosis, and vascular biology.